Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability, D-Dimer and Ultrasonography in Suspected Upper Extremity Deep Vein Thrombosis: A Prospective Management Study

Ankie Kleinjan, Marcello Di Nisio, Jan Beyer-Westendorf, Benilde Cosmi, Giuseppe Camporese, MD, Angelo Ghirarduzzi, Pieter W. Kamphuisen, MD, PhD, Hans-Martin Otten, MD, PhD, Ettore Porreca, Harry R. Büller, MD, PhD

Blood (2012) 120 (21): 391.

https://doi.org/10.1182/blood.V120.21.391.391

Published: 2012

Journal Articles

The EINSTEIN DVT Study: Does Localization of the Initial DVT Affect the Occurrence of Recurrent VTE While Patients Are on Anticoagulation?

Martin H Prins, Paolo Prandoni, Anthonie WA Lensing, Bonno van Bellen, Akos F Pap, Gary E Raskob, Harry R Büller

Blood (2011) 118 (21): 207.

https://doi.org/10.1182/blood.V118.21.207.207

Published: 2011

Journal Articles

The MAGELLAN Study: An Analysis of Outcomes Utilizing D-Dimer

Alexander T Cohen, Theodore E Spiro, Paul Burton, Harry R Büller, Lloyd Haskell, Da-Yi Hu, Russell D Hull, Alexandre Mebazaa, Geno J Merli, Sebastian Schellong, Alex C Spyropoulos, Victor F Tapson

Blood (2011) 118 (21): 542.

https://doi.org/10.1182/blood.V118.21.542.542

Published: 2011

Journal Articles

Safety and Clinical Utility of Four Clinical Decision Rules In the Diagnostic Management of Acute Pulmonary Embolism – the Prometheus Diagnosis Study

Inge CM Mos, MD, Renée A Douma, MD, Petra MG Erkens, MSc, Tessa AC Nizet, MD, Marc F Durian, MD, Anja A van Houten, MD, Marcel M Hovens, MD, Herman MA Hofstee, MD, Frederikus A Klok, MD, Hugo Ten Cate, MD, Erik F Ullmann, MD, Harry R Büller, MD, Pieter W Kamphuisen, MD, Menno V Huisman, MD

Blood (2010) 116 (21): 3186.

https://doi.org/10.1182/blood.V116.21.3186.3186

Published: 2010

Journal Articles

Thrombophilia and Cardiovascular Risk Factors On the Absolute Risk of First and Recurrent Venous Thrombosis. Results From a Retrospective Family Cohort Study Involving 2097 Relatives.

Anja B.U. MÄkelburg, MD, Saskia Middeldorp, MD, PhD, Karly Hamulyàk, MD, PhD, Martin Prins, MD, PhD, Harry R Büller, MD, PhD, Willem M. Lijfering, MD, PhD

Blood (2009) 114 (22): 2974.

https://doi.org/10.1182/blood.V114.22.2974.2974

Published: 2009

Journal Articles

Increased Sperm Count Maintains High Population Frequency of Factor V Leiden.

Danny M Cohn, MD, Sjoerd Repping, MD, PhD, Harry R Büller, MD, PhD, Joost CM Meijers, PhD, Saskia Middeldorp, MD, PhD

Blood (2009) 114 (22): 3994.

https://doi.org/10.1182/blood.V114.22.3994.3994

Published: 2009

Journal Articles

Recurrent Miscarriage in Women with and without Antiphospholipid Syndrome: Prognosis and Predictors of a Subsequent Successful Delivery.

Danny M Cohn, MD, Saskia Middeldorp, MD, PhD, Johanna C Korevaar, PhD, Feroza Dawood, Harry R Büller, MD, PhD, Mariëtte Goddijn, MD, PhD, Roy Farquharson, MD, FRCOG

Blood (2009) 114 (22): 2971.

https://doi.org/10.1182/blood.V114.22.2971.2971

Published: 2009

Journal Articles

High Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels May Protect against Recurrent Fetal Loss.

Hendrika M Knol, Nic J.G.M. Veeger, Saskia Middeldorp, Karly Hamulyàk, Martin H Prins, Harry R Büller, Jan van der Meer

Blood (2008) 112 (11): 1815.

https://doi.org/10.1182/blood.V112.11.1815.1815

Published: 2008

Journal Articles

Evidence for QTLs Influencing the Endogenous Thrombin Potential (ETP) and Protein C Concentrations in a Dutch Family with Unexplained Thrombophilia.

Michael W.T. Tanck, PhD, Iris M. Wichers, MD, Joost C.M. Meijers, PhD, Harry R. Büller, MD, Pieter H. Reitsma, PhD, Saskia Middeldorp, MD

Blood (2007) 110 (11): 132.

https://doi.org/10.1182/blood.V110.11.132.132

Published: 2007

Journal Articles

Once- or Twice-Daily Rivaroxaban for the Treatment of Proximal Deep Vein Thrombosis: Similar Efficacy and Safety to Standard Therapy in Dose-Ranging Studies.

Harry R. Büller, MD, Giancarlo Agnelli, MD, the EINSTEIN-DVT ODIXa-DVT Study Groups

Blood (2006) 108 (11): 572.

https://doi.org/10.1182/blood.V108.11.572.572

Published: 2006

Journal Articles

A New Oral Aniticoagulant, Dabigatran Etexilate, Is Effective and Safe in Preventing Venous Thromboembolism after Total Knee Replacement Surgery (The RE-MODEL Trial).

Bengt I. Eriksson, MD, PhD, Ola E. Dahl, MD,PhD, Cornelis N. van Dijk, MD,PhD, Simon P. Frostick, MA,DM,FRCS, Andreas A. Kurth, MD,PhD, Nadia Rosencher, MD, Janet Schnee, MD, Rohan Hettiarachchi, MD,PhD, Anita V. Christiansen, MSc.Pharm., Stefan Hantel, PhD, Harry R. Büller, MD,PhD

Blood (2006) 108 (11): 573.

https://doi.org/10.1182/blood.V108.11.573.573

Published: 2006

Journal Articles

Natural Course of the Subsequent Pregnancy after a Single Loss in Women with and without the Factor V Leiden or Prothrombin 20210A Mutations.

Michiel Coppens, Nienke Folkeringa, Margreet Teune, Karly Hamulyak, Jan van der Meer, Martin H. Prins, Harry R. Büller, Saskia Middeldorp

Blood (2006) 108 (11): 275.

https://doi.org/10.1182/blood.V108.11.275.275

Published: 2006

Journal Articles

The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study

Bernd-Jan Sanson, Paolo Simioni, Daniela Tormene, Marco Moia, Philip W. Friederich, Menno V. Huisman, Paolo Prandoni, Alessandra Bura, László Rejtő, Philip Wells, Pier M. Mannucci, Antonio Girolami, Harry R. Büller, Martin H. Prins

Blood (1999) 94 (11): 3702–3706.

https://doi.org/10.1182/blood.V94.11.3702

Published: 1999

Journal Articles

Double-Homozygosity for Factor V Leiden and the Prothrombin Gene G20210A Variant in a Young Patient With Idiopathic Venous Thrombosis

Johan R. Meinardi, Peter M. Pelsma, Hans Koning, Jan van der Meer, Saskia Middledorp, Harry R. Büller, Karly Hamulyák

Blood (1999) 94 (5): 1828–1829.

https://doi.org/10.1182/blood.V94.5.1828

Published: 1999

NARROW

Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability, D-Dimer and Ultrasonography in Suspected Upper Extremity Deep Vein Thrombosis: A Prospective Management Study

The EINSTEIN DVT Study: Does Localization of the Initial DVT Affect the Occurrence of Recurrent VTE While Patients Are on Anticoagulation?

The MAGELLAN Study: An Analysis of Outcomes Utilizing D-Dimer

Safety and Clinical Utility of Four Clinical Decision Rules In the Diagnostic Management of Acute Pulmonary Embolism – the Prometheus Diagnosis Study

Thrombophilia and Cardiovascular Risk Factors On the Absolute Risk of First and Recurrent Venous Thrombosis. Results From a Retrospective Family Cohort Study Involving 2097 Relatives.

Increased Sperm Count Maintains High Population Frequency of Factor V Leiden.

Recurrent Miscarriage in Women with and without Antiphospholipid Syndrome: Prognosis and Predictors of a Subsequent Successful Delivery.

High Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels May Protect against Recurrent Fetal Loss.

Evidence for QTLs Influencing the Endogenous Thrombin Potential (ETP) and Protein C Concentrations in a Dutch Family with Unexplained Thrombophilia.

Once- or Twice-Daily Rivaroxaban for the Treatment of Proximal Deep Vein Thrombosis: Similar Efficacy and Safety to Standard Therapy in Dose-Ranging Studies.

A New Oral Aniticoagulant, Dabigatran Etexilate, Is Effective and Safe in Preventing Venous Thromboembolism after Total Knee Replacement Surgery (The RE-MODEL Trial).

Natural Course of the Subsequent Pregnancy after a Single Loss in Women with and without the Factor V Leiden or Prothrombin 20210A Mutations.

The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study

Double-Homozygosity for Factor V Leiden and the Prothrombin Gene G20210A Variant in a Young Patient With Idiopathic Venous Thrombosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only